GSK Plc ADR [GSK] stock is trading at $38.40, up 1.16%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GSK shares have gain 5.64% over the last week, with a monthly amount glided 5.35%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GSK Plc ADR [NYSE: GSK] stock has seen the most recent analyst activity on April 15, 2025, when Exane BNP Paribas initiated its Neutral rating and assigned the stock a price target of $35.25. On November 15, 2024, downgrade downgraded it’s rating to Hold. Jefferies downgraded its rating to a Hold and decreased its price target to $39.50 on November 12, 2024. Guggenheim downgraded its rating to a Neutral. UBS downgraded its rating to Neutral for this stock on July 08, 2024. In a note dated May 30, 2024, Goldman initiated an Neutral rating and provided a target price of $47 on this stock.
GSK Plc ADR [GSK] stock has fluctuated between $31.72 and $45.79 over the past year. Currently, Wall Street analysts expect the stock to reach $35.25 within the next 12 months. GSK Plc ADR [NYSE: GSK] shares were valued at $38.40 at the most recent close of the market. An investor can expect a potential drop of -8.2% based on the average GSK price forecast.
Analyzing the GSK fundamentals
GSK Plc ADR [NYSE:GSK] reported sales of 40.23B for the trailing twelve months, which represents a growth of 1.38%. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.22 and Total Capital is 0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, GSK Plc ADR’s Current Ratio is 0.87. Further, the Quick Ratio stands at 0.58, while the Cash Ratio is 0.21. Considering the valuation of this stock, the price to sales ratio is 1.93, the price to book ratio is 4.29 and price to earnings (TTM) ratio is 19.94.
Transactions by insiders
Recent insider trading involved GSK plc, 10% Owner, that happened on Sep 27 ’24 when 2.79 million shares were purchased.
